Figure 3
From: HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer

Flow chart of patient selection in this study. HER2, Human epidermal growth factor receptor 2.
From: HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer

Flow chart of patient selection in this study. HER2, Human epidermal growth factor receptor 2.